Clinical Trials Browser

Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Hodgkin Disease, Liver Neoplasms, Lymphoma, Melanoma, Stomach Neoplasms, Carcinoma, Merkel Cell, Neoplasms, Squamous Cell, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT00282100 2019-04-16

Adjuvant Therapy of Gefitinib (Iressa, ZD1839) in Patients With Resectable Hepatocellular Carcinoma

Phase 2 Unknown

40 enrolled

Gastrointestinal

Liver Neoplasms

NCT02632864 2018-04-12

Feasibility of High Dose PROton Therapy On Unresectable Primary Carcinoma Of Liver: Prospective Phase II Trial

Phase 2 Unknown

66 enrolled

Gastrointestinal

Liver Neoplasms

NCT01217034 2017-10-31

TACTICS

Phase 2 Unknown

228 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT02969096 2016-11-21

Clinical Study of Targeted Cryoablation Therapy in the Treatment of Hepatic Carcinoma

Phase 2 Unknown

30 enrolled

Gastrointestinal

Liver Neoplasms

NCT02363218 2016-10-07

Study on Effectiveness and Safety of Hepatocellular Carcinoma Patients Treated With CyberKnife

Phase 2 Unknown

117 enrolled

Gastrointestinal

Liver Neoplasms

NCT00077389 2014-06-24

Intensive Neoadjuvant Chemotherapy in Treating Young Patients Undergoing Surgical Resection for High-Risk Hepatoblastoma

Phase 2 Unknown

57 enrolled

Gastrointestinal

Liver Neoplasms, Hepatoblastoma

NCT00003044 2013-12-19

Chemotherapy in Treating Patients With Liver Cancer

Phase 2 Unknown

55 enrolled

Gastrointestinal

Liver Neoplasms

NCT00003296 2013-12-19

Liposomal Doxorubicin in Treating Patients With Liver or Bile Duct Cancer

Phase 2 Unknown

26 enrolled

Gastrointestinal

Bile Duct Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms

NCT00276705 2013-09-17

Combination Chemotherapy and Thalidomide in Treating Younger Patients Undergoing Surgery For Newly Diagnosed Liver Cancer

Phase 2 Unknown

47 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00287976 2013-09-17

Irinotecan in Treating Young Patients With Refractory or Recurrent Hepatoblastoma

Phase 2 Unknown

30 enrolled

Gastrointestinal

Liver Neoplasms, Hepatoblastoma

NCT01895010 2013-07-10

Acupoint Electric Stimulation Combined With Tropisetron in Preventing and Treating Nausea and Vomiting After TACE

Phase 2 Unknown

74 enrolled

Gastrointestinal

Liver Neoplasms, Nausea, Vomiting

NCT01858207 2013-05-23

Combine TACE and RFA Versus RFA Monotherapy in Unilobar HCC of 3.1 to 7 cm Patient

Phase 2 Unknown

60 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT01423708 2012-07-18

EPOCAL

Phase 2 Unknown

117 enrolled

Gastrointestinal

Liver Cirrhosis, Liver Diseases, Liver Neoplasms, Liver Failure

NCT01556815 2012-04-25

Sorafenib Combined With Transarterial Chemoembolization in Treating HBV-infected Patients With Intermediate Hepatocellular Carcinoma

Phase 2 Unknown

40 enrolled

Gastrointestinal

Adenocarcinoma, Carcinoma, Digestive System Neoplasms, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial

NCT00659022 2011-09-12

Neo-adjuvant Therapy and the Effect on Synchronous Metastatic Growth

Phase 2 Unknown

60 enrolled

Gastrointestinal

Liver Neoplasms, Colorectal Neoplasms

NCT00471484 2011-06-22

Combination Chemotherapy and Interferon Alfa-2b in Treating Patients With Nonmetastatic Liver Cancer That Cannot Be Removed by Surgery

Phase 2 Unknown

54 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT01182272 2010-08-16

Sorafenib Tosylate in Treating Patients With Liver Cancer That Can Be Removed by Surgery

Phase 2 Unknown

36 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00247260 2007-03-15

Safety of 32P BioSilicon in Patients With Hepatocellular Carcinoma

Phase 2 Unknown

50 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00356161 2006-07-25

HAI Via Interventionally Implanted Port Catheter Systems

Phase 2 Unknown

100 enrolled

Gastrointestinal

Bile Duct Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms, Colorectal Neoplasms

NCT00290316 2006-06-07

Accuracy of Endoscopic Ultrasound for Detection of Tumors of the Liver

Phase 2 Unknown

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasm Metastasis, Cholangiocarcinoma

NCT00152087 2005-09-09

A Non-Randomized Study of Internal Radiation Therapy to the Liver in Patients With Primary Liver Cancer for Whom Surgery is Not Possible.

Phase 2 Unknown

25 enrolled

Gastrointestinal

Liver Neoplasms

NCT00006198 2005-06-24

Chronic Thalidomide Administration in Patients Undergoing Chemoembolization for Unresectable Hepatocellular Cancer

Phase 2 Unknown

Gastrointestinal

Liver Neoplasms

Clinical Trials

Tislelizumab Plus TKI as Adjuvant Therapy Versus Active Surveillance in Patients With HCC

High Dose Vitamin C Combined With Metformin in the Treatment of Malignant Tumors

Hepatic Artery Infusion Chemotherapy Plus Donafenib in Patients With Hepatocellular Carcinoma After Surgery

HCC

Axitinib Plus Toripalimab as Second-line Treatment in Hepatobiliary Malignant Tumors

COLT

Clinical Recruitment of Patients With First-line Targeted Drug Resistance or Intolerance to Hepatocellular Cancer With PD-1 Inhibitor (Toripalimab,JS001) Detected on the NGS Platform Combined With Anlotinib

A Randomized Phase II Trial of Surgery Plus Sorafenib vs. Sorafenib Alone for Hepatocellular Cancer (HCC) With Portal Vein Invasion

Study of Activated CIK Armed With Bispecific Antibody for Advanced Liver Cancer

HAIC Combined With Bevacizumab and Toripalimab for Advanced Hepatocellular Carcinama

DC-CIK

Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.

Adjuvant Therapy of Gefitinib (Iressa, ZD1839) in Patients With Resectable Hepatocellular Carcinoma

Feasibility of High Dose PROton Therapy On Unresectable Primary Carcinoma Of Liver: Prospective Phase II Trial

TACTICS

Clinical Study of Targeted Cryoablation Therapy in the Treatment of Hepatic Carcinoma

Study on Effectiveness and Safety of Hepatocellular Carcinoma Patients Treated With CyberKnife

Intensive Neoadjuvant Chemotherapy in Treating Young Patients Undergoing Surgical Resection for High-Risk Hepatoblastoma

Chemotherapy in Treating Patients With Liver Cancer

Liposomal Doxorubicin in Treating Patients With Liver or Bile Duct Cancer

Combination Chemotherapy and Thalidomide in Treating Younger Patients Undergoing Surgery For Newly Diagnosed Liver Cancer

Irinotecan in Treating Young Patients With Refractory or Recurrent Hepatoblastoma

Acupoint Electric Stimulation Combined With Tropisetron in Preventing and Treating Nausea and Vomiting After TACE

Combine TACE and RFA Versus RFA Monotherapy in Unilobar HCC of 3.1 to 7 cm Patient

EPOCAL

Sorafenib Combined With Transarterial Chemoembolization in Treating HBV-infected Patients With Intermediate Hepatocellular Carcinoma

Neo-adjuvant Therapy and the Effect on Synchronous Metastatic Growth

Combination Chemotherapy and Interferon Alfa-2b in Treating Patients With Nonmetastatic Liver Cancer That Cannot Be Removed by Surgery

Sorafenib Tosylate in Treating Patients With Liver Cancer That Can Be Removed by Surgery

Safety of 32P BioSilicon in Patients With Hepatocellular Carcinoma

HAI Via Interventionally Implanted Port Catheter Systems

Accuracy of Endoscopic Ultrasound for Detection of Tumors of the Liver

A Non-Randomized Study of Internal Radiation Therapy to the Liver in Patients With Primary Liver Cancer for Whom Surgery is Not Possible.

Chronic Thalidomide Administration in Patients Undergoing Chemoembolization for Unresectable Hepatocellular Cancer